Consensus $9.25. The company said, “The company raised its fiscal year 2026 outlook for non-GAAP diluted EPS to $9.30 to $9.50, a $0.20 increase from the preliminary outlook of $9.10 to $9.30 previously communicated during the company’s 2025 Investor Day.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health to acquire Solaris Health for $1.9B in cash, sees accretion
- Notable companies reporting before tomorrow’s open
- CAH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cardinal Health expands Equity Rx across Ohio
- Cardinal Health price target raised to $190 from $181 at Morgan Stanley